Castellum, Inc. (NYSEAMERICAN:CTM – Get Free Report) was the target of a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 332,300 shares, an increase of 228.7% from the October 31st total of 101,100 shares. Based on an average trading volume of 1,470,000 shares, the short-interest ratio is presently 0.2 days. Currently, 1.1% of the company’s shares are sold short.
Castellum Price Performance
Castellum stock traded up $0.04 during mid-day trading on Thursday, hitting $0.20. The stock had a trading volume of 2,259,130 shares, compared to its average volume of 868,207. Castellum has a 12 month low of $0.12 and a 12 month high of $0.40. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.63. The stock has a market cap of $11.50 million, a price-to-earnings ratio of -1.21 and a beta of -3.14.
Hedge Funds Weigh In On Castellum
An institutional investor recently raised its position in Castellum stock. Virtu Financial LLC boosted its position in Castellum, Inc. (NYSEAMERICAN:CTM – Free Report) by 82.2% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 103,288 shares of the company’s stock after buying an additional 46,606 shares during the quarter. Virtu Financial LLC owned approximately 0.19% of Castellum worth $27,000 as of its most recent filing with the SEC. Institutional investors own 3.39% of the company’s stock.
Castellum Company Profile
Castellum, Inc provides services in the areas of cybersecurity, information technology, electronic and information warfare, and information operations. Its services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model based systems engineering services.
Featured Articles
- Five stocks we like better than Castellum
- Insider Buying Explained: What Investors Need to Know
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Consumer Discretionary Stocks Explained
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Castellum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castellum and related companies with MarketBeat.com's FREE daily email newsletter.